Capital & Planning LLC’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.79M Buy
6,743
+4,010
+147% +$1.06M 0.88% 20
2026
Q2
$694K Buy
2,733
+1,889
+224% +$440K 0.36% 31
2026
Q1
$206K Buy
+844
New +$197K 0.13% 42
2025
Q3
– Sell
-14,779
Closed -$2.26M – 40
2025
Q2
$2.26M Sell
14,779
-3,261
-18% -$501K 1.53% 17
2025
Q1
$2.99M Sell
18,040
-463
-3% -$72.4K 2.22% 12
2024
Q4
$2.68M Buy
+18,503
New +$2.87M 1.96% 12

Other funds holding JNJ

Capital & Planning LLC's JNJ Position: Q3 2026 in Review

Capital & Planning LLC increased its Johnson & Johnson (JNJ) stake by 147% in Q3 2026, buying an estimated $1.06M and bringing the position to 6,743 shares worth $1.79M. The position accounts for 0.88% of the portfolio, ranked #20.

Capital & Planning LLC first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.99M in Q1 2025. 4,725 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Capital & Planning LLC held 6,743 shares of Johnson & Johnson worth $1.79M as of Q3 2026.
  • Capital & Planning LLC bought 4,010 Johnson & Johnson shares in Q3 2026, an estimated $1.06M.
  • Johnson & Johnson made up 0.88% of Capital & Planning LLC's portfolio in Q3 2026, its #20 holding.
  • Capital & Planning LLC first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • Capital & Planning LLC's Johnson & Johnson position peaked at $2.99M in Q1 2025.
  • 4,725 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Capital & Planning LLC's 13F filing for Q3 2026, filed 16 Nov 2026.